Basel, Switzerland – June 30, 2026 – athagoras announces that Horiana is joining the Group, deepening its pan-European Real-World Evidence platform with the addition of French health data expertise. Together with the Group’s established capabilities, athagoras now holds direct access to Europe’s four richest health data environments – France, Nordics, Germany, and the UK – integrated within a single evidence partner.
Horiana brings deep French RWE expertise across epidemiology, biostatistics, advanced methods on primary and secondary data studies. Its mastery of the nationwide French health data sources, including SNDS and PMSI, gives athagoras direct access to one of Europe’s richest and most consequential healthcare datasets, complementing the Group’s established capabilities in Nordic registries and strengthening its ability to generate robust, submission-ready evidence.
By combining Horiana’s French RWE depth with the Group’s existing capabilities in market access, regulatory affairs, and technology, athagoras is now positioned to support pharmaceutical and biotech clients from evidence strategy through JCA, payer engagement, and national reimbursement without handoffs, and with genuine local expertise in every market that matters.
“Horiana is a major addition to our RWE platform,” said Giuseppe Pileggi, CEO of athagoras. “The team brings the scientific depth and data expertise needed to answer increasingly complex evidence questions for healthcare decision-making. With privileged access to Nordic registries and the French national health data system, now both within the Group, we can deliver the kind of pan-European evidence that JCA and national payers increasingly require with boutique rigor at every step.”
Céline Fabre, CEO of Horiana, added: “Joining athagoras is a natural next step for Horiana. We share the same culture and the same ambition to deliver innovative and trusted evidence. This combination allows us to bring our French RWE and methodological expertise into a broader European platform, while continuing to serve clients with the scientific standards and entrepreneurial approach that define who we are.”
Kirk Geale, Head of athagoras RWE, commented that “Horiana’s French RWE expertise is highly complementary to athagoras’ established strengths in the Nordics, Germany, and UK. Together, we can help clients navigate Europe’s diverse health data and create robust, fit-for-purpose evidence for regulatory, clinical, and commercial decision-making.”
athagoras is building the specialist European partner for evidence and access combining boutique expertise, scientific excellence, and coordinated execution across every market that matters. Your Gateway to Europe®
